A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Name: A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
License: Public Domain

Nuvalent Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

locally advanced solid tumor, metastatic solid tumor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429750
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.